Pyelonephritis clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)
open to eligible people ages 18 years and up
The Next Day Clinic (NDC) is a quality improvement initiative that will be launched and operated by UCLA Health starting July 22, 2024. Its goals are to improve patient care and safety and to maximize cost effectiveness. The way it does this is by…
at UCLA
Our lead scientists for Pyelonephritis research studies include Richard K. Leuchter, MD.
Last updated: